1. Home
  2. EPRT vs COGT Comparison

EPRT vs COGT Comparison

Compare EPRT & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Essential Properties Realty Trust Inc.

EPRT

Essential Properties Realty Trust Inc.

HOLD

Current Price

$31.50

Market Cap

6.6B

Sector

Real Estate

ML Signal

HOLD

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$34.61

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPRT
COGT
Founded
2016
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
5.9B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
EPRT
COGT
Price
$31.50
$34.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
15
Target Price
$36.79
$36.21
AVG Volume (30 Days)
2.0M
1.6M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
3.98%
N/A
EPS Growth
11.30
N/A
EPS
0.28
N/A
Revenue
$561,219,000.00
$7,871,000.00
Revenue This Year
$17.12
N/A
Revenue Next Year
$16.27
$1,733.58
P/E Ratio
$112.11
N/A
Revenue Growth
24.82
N/A
52 Week Low
$28.95
$4.55
52 Week High
$34.73
$43.73

Technical Indicators

Market Signals
Indicator
EPRT
COGT
Relative Strength Index (RSI) 46.80 38.82
Support Level $29.30 $33.26
Resistance Level $31.79 $37.79
Average True Range (ATR) 0.63 1.32
MACD -0.03 -0.19
Stochastic Oscillator 24.40 0.32

Price Performance

Historical Comparison
EPRT
COGT

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: